Presentation Time:

11/15/2005 9:30:00 AM

Title:

Predictive Value of Microvolt T-Wave Alternans for Sudden Cardiac Death in Patients with Preserved Left Ventricular Function after Myocardial Infarction: Results of a Collaborative Cohort

Keywords:

Risk factors,Sudden death,Myocardial infarction,Electrocardiography,Ventricular arrhythmia

Author Block:

Takanori Ikeda, Kyorin University, Tokyo, Japan; Kaoru Sugi, Toho University, Tokyo, Japan; Hiroki Shimizu, Hyogo College of Medicine, Nishinomiya, Japan; Jun Watanabe, Tohoku University, Sendai, Japan; Yuji Kasamaki, Nihon University, Tokyo, Japan; Akihiro Yoshida, Kobe University, Kobe, Japan; Kaoru Tanno, Showa University, Tokyo, Japan; Hideaki Yoshino, Kyorin University, Tokyo, Japan; Takao Kato, Nippon Medical School, Tokyo, Japan

Disclosure Block:

 T. Ikeda, None; K. Sugi, None; H. Shimizu, None; J. Watanabe, None; Y. Kasamaki, None; A. Yoshida, None; K. Tanno, None; H. Yoshino, None; T. Kato, None.

Unlabeled/unapproved:

There are no unlabeled/unapproved uses of drugs or products.

There are numerous reports regarding risk stratification in patients with reduced left ventricular ejection fraction (LVEF) after myocardial infarction (MI). However, few data are available in MI patients with preserved LVEF. Although prognosis of patients with preserved LVEF is better than that of patients with reduced LVEF, risk stratification in such patients is also important in patient care. Microvolt T-wave alternans (TWA) is associated with increased risk of arrhythmic events in MI patients. In this study, we conducted a collaborative cohort of patients with preserved LVEF after MI to evaluate the predictive power of TWA. Methods: This prospective study enrolled 1012 patients who had LVEF >40% (average 54±10%) after MI. Patients with persistent atrial fibrillation were excluded from the study. All patients underwent a TWA testing a mean of 1.7±2.2 months after acute MI and results were categorized as positive, indeterminate, or negative. Other 10 prognostic indices such as late potentials (LP) by signal-averaged electrocardiography and nonsustained ventricular tachycardia (NSVT) on Holter monitoring were also evaluated in this population. The primary endpoint was prospectively defined as sudden cardiac death or cardiac arrest. Results: During a mean follow-up period of 32±14 months, 37 patients (3.7%) died of nonarrhythmic causes such as stroke, pneumonia, cancer, and so on. These patients were not considered for the present analysis. Of the 975 patients, 18 patients (1.8%) reached one of the primary endpoints. TWA was positive in 167 patients (17%), negative in 724 (74%), and indeterminate in 84 (9%). Univariate analysis revealed that TWA predicted primary events with a relative hazard (RH) of 23.2 (P<0.0001). NSVT and LP also had significant values (RH: 6.2, P=0.0001 and RH: 5.8, P=0.0006, respectively). To test which index has the most significant value to predict primary endpoints, we performed multivariate Cox regression analysis. TWA was the most powerful predictors (RH: 18.9, 95% CI: 5.1-69.3, P<0.0001). Conclusions: TWA is thus a strong predictor for sudden cardiac death in patients with preserved LVEF >40% after acute MI. It may be useful in identifying patients who need implantable cardioverter defibrillator in this population.

 

American Heart Association